301 Gene expression and genetic mutation contributing to variety of basal cell carcinoma
نویسندگان
چکیده
Basal cell carcinoma (BCC) has a variety of clinical and histological divergence. For instance, morpheaform BCC is rare subtype with poor prognosis. BCCs in Asian people can be diagnosed based on the characteristic pigment features through dermoscopy, while Caucasian usually lack pigmentation, which often make diagnosis more difficult. Trichoblastoma benign tumor, although it closely resembles to dermoscopy features. Factors that contribute diversity have not yet been known. We surveyed distinction among BCC, trichoblastoma, common also variances between nonpigmented pigmented from viewpoint gene expression genetic mutations. Transcriptomic analysis was performed 6 cases nodular 3 trichoblastoma. In addition, exome 5 (3 Japanese, 2 Caucasian) Compared type BCCs, genes belonging MAGE PRAME families were frequently expressed BCCs. Particularly MAGE-A2 strongly skin lesion observed by immunohistochemical study. Genes related hemoglobin blood coagulation fibrinolytic system including HBG1, FGA, APOH highly BCC. CGB5, encoding gonadotropin, one specifically commonly trichoblastomas. isoforms are aberrantly wide human cancers, each development maintenance cancer cells, metastasis invasion, respectively. High might key its invasive local destruction
منابع مشابه
Proteomic Analysis of Gene Expression in Basal Cell Carcinoma
Background: Basal Cell Carcinoma (BCC) is a type of non-melanoma skin cancer. Alteration in gene expression is the important event that happens in cancer cell. Detection of this event is possible by proteomics techniques. Methods: Normal and tumor tissues were taken from BCC patient. Total proteins were purified by standard methods, and proteins were separated by two-dimensional electrophoresis...
متن کاملComparison of COX2 expression in radiation induced basal cell carcinoma and non-radiation induced basal cell carcinoma
Background: Radiation-induced basal cell carcinoma (BCC) can be multiple, large, and recurring, which complicates its treatment in some cases. According to reports on the role of cyclooxygenase 2 (COX2) inhibitors in the treatment or prevention of non-melanoma skin cancers and considering the fact that COX2 expression has not been evaluated in radiation-in...
متن کاملValue of CD10 Expression in Differentiating Cutaneous Basal from Squamous Cell Carcinomas and Basal Cell Carcinoma from Trichoepithelioma
Background: In addition to the well-defined histological criteria for squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), immunohistochemical techniques can be used in difficult cases for their differentiation. As differential diagnosis between trichoepithelioma (TE) and BCC is sometimes difficult for the clinician and the pathologist, CD10 may be a useful marker for definite diagnosi...
متن کاملBasal cell carcinoma of the lower extremities
Background: Basal cell carcinoma (BCC), the most common form of skin cancer, usually occurs in the sun-exposed areas of the body like head and neck, yet is also seen in unexpected sites. Myriad studies have mentioned a lower limb BCC incidence rate of 1.5-13.5%.Methods: The present retrospective cross-sectional study was conducted on 650 BCC patients, who were referred to the dermatology tumor ...
متن کاملThe Usefulness of CD10 in Distinguishing between Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
Background & Objectives: CD10 is a cell surface enzyme with metalloendopeptidase activity, also known as Common Acute Lymphoblastic Leukaemia Antigen, which mainly serves as a marker for acute lymphoblastic leukemia (ALL). To date and to the best of our knowledge, only few comparative immunohistochemical studies have assessed CD10 expression in cutaneous epithelial neoplasms. Our goal was to d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Investigative Dermatology
سال: 2023
ISSN: ['1523-1747', '0022-202X']
DOI: https://doi.org/10.1016/j.jid.2023.03.305